Connecting biology with clinical intent to empower forward-thinking medicine
A forward-thinking corporate officer and executive leader with deep academic and business experience at all stages of pipeline management from clinical through to launch, and a unique deeply clinical lifecycle management approach representing science creativity. The ability to link strategy with executional excellence, an understanding of regulatory and geographic business and access environments joined to sensitivity to corporate culture.
A visionary creative mind with a deep appreciation of talents, organizational models, clarity and consistency in communication; known for walking the talk and a strong capacity for getting the basics right.
A reputation for being authentic, inspiring large teams across continents and functions, and building trusted relationships to allow candid dialogue. A facilitator connecting biology with clinical medicine.
A basic research Immunologist and hospital clinician, trained in dermatology, and specializing in targeted therapies. Moved mountains to build a center of excellence for modern therapeutics in immunodermatology. A clinical launch expert in industry who has held executive leadership positions in big pharma. Chief Innovation Officer and consultant for venture funds and biotechs on science, launchability and clinical development questions.
A mother of 5 and a continuous learner; grounded and pragmatic thanks to my children, who remind me of my own growth opportunities every day.
Gained an MBA in change management in 2011 and enrolled in the Executive Master of Change program at INSEAD, helping executives to decelerate and learn how we interact with systems, how to transform them and how much success has to do with ourselves.
The passion for biology and “How does this work?” never fades. No question is too basic. Modern medicine takes advantage of molecular patterns in disease as well as advances in biotechnology to engineer bespoke assets that aim to block a pathological process at its roots. I feel privileged to have been able to apply targeted science across multiple launches and the portfolio expansion of Abbvie across geographies in my 14 years of leadership. Now elevating innovation in precision medicine as Chief Innovation Officer and Group Vice President Diagnostics at Danaher.
A visionary creative mind with a deep appreciation of talents, organizational models, clarity and consistency in communication; known for walking the talk and a strong capacity for getting the basics right.
A reputation for being authentic, inspiring large teams across continents and functions, and building trusted relationships to allow candid dialogue. A facilitator connecting biology with clinical medicine.
A basic research Immunologist and hospital clinician, trained in dermatology, and specializing in targeted therapies. Moved mountains to build a center of excellence for modern therapeutics in immunodermatology. A clinical launch expert in industry who has held executive leadership positions in big pharma. Chief Innovation Officer and consultant for venture funds and biotechs on science, launchability and clinical development questions.
A mother of 5 and a continuous learner; grounded and pragmatic thanks to my children, who remind me of my own growth opportunities every day.
Gained an MBA in change management in 2011 and enrolled in the Executive Master of Change program at INSEAD, helping executives to decelerate and learn how we interact with systems, how to transform them and how much success has to do with ourselves.
The passion for biology and “How does this work?” never fades. No question is too basic. Modern medicine takes advantage of molecular patterns in disease as well as advances in biotechnology to engineer bespoke assets that aim to block a pathological process at its roots. I feel privileged to have been able to apply targeted science across multiple launches and the portfolio expansion of Abbvie across geographies in my 14 years of leadership. Now elevating innovation in precision medicine as Chief Innovation Officer and Group Vice President Diagnostics at Danaher.
